All posts by: Michael Zand

About Michael Zand

‘Suicide molecule’ could lead to fail-safe cancer therapy, scientists say – Times & Star

Continue reading

2017-10-20 NEWS

Times & Star

‘Suicide molecule’ could lead to fail-safe cancer therapy, scientists say
Times & Star
Immunotherapy treatment had been partially successful because it is geared towards activating one of nature’s anti-cancer mechanisms, said Prof Peter. However, few cancers responded to immunotherapy and only a few patients benefited. He added: “Our …

and more »

Continue reading

2017-10-20 NEWS

California moves against unlicensed stem–cell treatments — but is it doing enough?
Los Angeles Times
Unlicensed stem–cell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stem–cell” solution was injected …

Continue reading

2017-10-20 NEWS

California moves against unlicensed stem–cell treatments — but is it doing enough?
Los Angeles Times
Unlicensed stem–cell treatments aren’t innocuous — some have resulted in permanent injury to customers. Among other cases, three elderly women were reported this year to have lost all or part of their vision after a “stem–cell” solution was injected …

Continue reading

2017-10-20 NEWS

CAR-T immunotherapy now approved for certain adult lymphoma patients
Medical Xpress
The Food and Drug Administration (FDA) has approved a breakthrough cancer therapy known as CAR-T for use in adults with advanced lymphoma. The therapy uses a patient’s own white blood cells, which are modified in a lab and re-trained to recognize …

and more »

Continue reading

2017-10-20 NEWS

WBUR

For Some, Cutting-Edge ‘CAR–T‘ Treatment Unleashes ‘Pac-Man’ Cells Against Blood Cancer
WBUR
This week, the U.S. Food and Drug Administration approved the second therapy in this class, called Yescarta, to treat advanced B-cell lymphomas, like Wilkins’. The first CAR–T drug, Kymriah, received approval in August to treat an advanced form of …
New CAR–T cell therapy offers effective option for certain blood cancer patientsNews-Medical.net
CAR–T could revolutionize cancer treatment. It can also be fatalMassive
Personalized Gene Therapy Shows Promise For Certain Blood CancersCBS Miami

all 7 news articles »

Continue reading

2017-10-20 NEWS

Boston Herald

CAR-T immunotherapy may help blood cancer patients who don’t respond to standard treatments
Medical Xpress
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved by the Food and Drug …
Thumbs Up to Latest CAR T-Cell ApprovalMedPage Today
For Some, Cutting-Edge ‘CAR-T’ Treatment Unleashes ‘Pac-Man’ Cells Against Blood CancerWBUR

all 7 news articles »